Who is Frances Kelsey? Well, she's a semi-unsung hero of the FDA whose work helped save a lot of kids from congenital disorders and even death. Listen and learn!
See omnystudio.com/listener for privacy information.
No summary for this episode yet.
This is an iHeart Podcast. Guaranteed human. Living with an autoimmune condition isn't easy, and every journey is different. That's why Season 5 of Untold Stories, Life with a Severe Autoimmune Condition, from Ruby Studio and Argenix, shares powerful firsthand stories from people with conditions like MG and CIDP. Hosted by Martine Hackett, these conversations dive into what resilience really looks like through setbacks, breakthroughs, and finding strength in community. Listen on the iHeart Radio app, Apple Podcasts, or wherever you get your podcasts. Hey, and welcome to The Short Stuff. I'm Josh, and there's Chuck, and Jerry's here too.
Dave's here in spirit. This is Short Stizoff. That's right. Right out of the gate, we should thank our old colleagues at HowStuffWorks.com and Joanna Thompson, who wrote the article that this one is based on. And I thought she did a great job. this is really kind of a great little packed-in shorty. It really is. And I think the gist of it is it's a tribute to not an unsung hero, but maybe one of the great heroes of the 20th century that you may not have heard of, a woman named Frances Oldham. Yeah, she was kind of sung. Yeah, she was. Definitely, in her lifetime, which is great. I think that there was an award created by the FDA and named in her honor, and they bestowed it upon her, the first one, in 2010.
So she's definitely gotten recognition, but I don't know that the average American walking around knows her name. Yeah, she's partially sung. She's like a Lou Reed song. She's semi-sung. Semi-sung? Partially sung like a Lou Reed song. Yeah, you know, he didn't really sing. Oh, gotcha. No, he talked a lot. He sort of talks things. Maybe kind of proto-wrapped a little bit, too. I don't know about that. Okay. All right. So let's talk about this great woman in our American history. That was a very stumbly way to say that, but that's what she was. She worked for the FDA. The FDA back in those days, and this was, what, the 1950s that she was working there.
60s, sorry. Into the 60s. I think she started in. 1960. Okay. Like I said, solidly 60s. But the FDA back then had a very different process for getting drugs on the market. It was not as rigorous. I think they had about 60 days to look over data on, you know, testing done usually on mice. And their supervisor was going, come on, hurry up, hurry up, like over their shoulder the whole time. Basically. And that's kind of how it went until Frances Kelsey came along. That was her name by marriage. She was born Frances Oldham on Vancouver Island and was very well schooled, got a master's in Montreal, got a Ph.
D. and an M.D. Her Ph.D. was in pharmacology, no surprise, from the University of Chicago. And she would go on to work there where she met her husband, Dr. Fremont Kelsey, and she became then Frances Oldham Kelsey. and, you know, it seemed like they were birds of a feather. They were both really into science, had a couple of daughters, and then moved to D.C. and she got a job at the FDA. Yeah, that's a pretty great setup. Should we take a break now? Oh, why not? Let's take an early break. Okay. Support for the show comes from Public, the investing platform for those who take it seriously. On Public, you can build a multi-asset portfolio of stocks, bonds, options, crypto, and now generated assets, which allow you to turn any idea into an investable index with AI.
It all starts with your prompt. From renewable energy companies with high free cash flow to semiconductor suppliers growing revenue over 20% year over year, you can literally type any prompt and put the AI to work. It screens thousands of stocks, builds a one-of-a-kind index, and lets you backtest it against the S&P 500. Then you can invest in a few clicks. Generated assets are like EFTs with infinite possibilities, completely customizable and based on your thesis, not someone else's. Go to public.com slash podcast and earn an uncapped 1% bonus when you transfer your portfolio. That's public.com slash podcast.
Paid for by public investing brokerage services by open to the public investing inc member finra sipc advisory services by public advisors llc sec registered advisor generated assets is an interactive analysis tool output is for informational purposes only and is not investment recommendation or advice complete disclosures available at public.com slash disclosures everybody knows shack but off camera he's just a regular guy people never believe me when i say i'm just like them i take out the trash, do dishes, and I struggle with moderate obstructive sleep apnea or OSA. And a lot of adults with obesity also struggle with moderate to severe OSA.
You know those scary breathing interruptions during sleep, the loud snoring, choking, and daytime fatigue? I knew I had to talk to my doctor. Don't sleep on the symptoms. Learn more at dontsleeponosa.com. This information is provided by Lilly, a medicine company. So, Chuck, you set us up perfectly. Dr. Kelsey is at the FDA, brand new position, after about seven months, and her position was to basically check scientific data to approve or disapprove new drugs for the FDA, right? Yeah. About seven months after she starts, and she was just a handful of medical people who were actually doing that.
and had 60 days to do it. But about seven months after she started, a drug approval application for a drug called thalidomide crossed her desk. And she said, oh, what's this? She did. It came in from the American version, was from the Richardson Merrill Company. And they were really eager to get it going because this drug had been kind of the hot ticket in Africa and in Europe and I think a couple of other places around the world. It was huge in Germany. Very big in West Germany. They did not approve it in East Germany. So it was a sedative. It was an anti-anxiety drug, basically. It was developed in the 50s.
It was a post-war drug, and they were like in every way, because they were like, people really need to settle down, and they need sedatives. People need to sleep. So this thing, thalidomide does a great job at that. And so people started taking it. And they were like, hey, not only does it help me sleep, but it helps my tum-tum feel better. So all of a sudden, pregnant women were like, this is really working well for my morning sickness. Yeah. And this had been going on, I think it came out in 1952. This is 1960 when Dr. Kelsey gets the application. So, I mean, it had been kind of proven effective and safe, essentially, throughout the rest of the world.
So there was an expectation, I'm sure, by the drug company that this would just sail through rather easily, the application and review process. But Dr. Kelsey was a bit of a stickler, fortunately. And she said, well, let me really take a look at the science. And she found that there were reports of neuropathy where people like lose sensation in their extremities. Their nerve endings are basically damaged. And it's true when you stop taking thalidomide, the sensation came back to your extremities. But that's kind of weird. And she didn't really understand that. She also found that pregnant women taking it off-label for morning sickness, there was basically no studies on that.
So as far as Dr. Kelsey was concerned, there was not enough scientific data coming across her desk for her to approve this, and she wanted more. Yeah, and a couple of remarkable details here. The company, Richards and Merrill, they came back to her six times trying to get this thing through and were putting the heat on her in a big way. And the other thing is you said they didn't do any tests on pregnancy. This is because at the time, doctors still didn't think that drugs that pregnant women took could pass the placental barrier. Oh, okay. So she was sort of ahead of the curve in a lot of ways by thinking like, well, maybe something is happening here, even though doctors say that's impossible.
Maybe we should look at it closer. And she held her ground through those six times. Yeah. it turns out the West Germans who developed this drug only test, or at the time, I guess, only tested drugs for toxicity and not, you know, stuff like neuropathy and other, like, side effects. So you give it to somebody and be like, did it kill you? Yeah. No? Great. It was a toxic, so they let it ride. Yeah. And, you know, the history of thalidomide, I mean, Billy Joel included it in. We didn't start the fire for a reason. That was a big deal. Yeah, huge. It was a very big deal. So Dr. Kelsey's holding her ground.
She just wants more scientific data, and the company's not giving her what she wants. And meanwhile, there's two doctors, one in Australia named Dr. William McBride, one in Germany, Dr. Vedukund Lintz. Did I say that right? Yes. Yes. And they both started to notice that there was a cluster of children being born with birth deformities and that they were very specific but very rare birth deformities, in particular, feet and hands protruding directly from shoulders and hips. That's a very specific kind of birth deformity that you can have, but it's exceedingly rare. So a bunch of kids suddenly being born with that birth defect, it caught their attention.
And they started to do some investigating, and they figured out that the one commonality that all of those mothers had was that they had taken thalidomide early in their pregnancy for morning sickness. And they published a paper as fast as they could in The Lancet saying, stop prescribing thalidomide. Yeah. I mean, not only prescribing in West Germany, it was over the counter. Yeah. So you could just grab this stuff and take it. In the end, about 10,000 kids were affected. The aforementioned Billy Joel's children of thalidomide is what they were known as. About 40% of those died at birth because it was not only like these deformities of the limbs really is what grabbed their attention.
But heart troubles and stuff like that was also a big problem. Right. And, you know, 40% of them died sort of around birth or at birth. Most of these kids were in West Germany, like I said, because they developed the drug. And so I just think it was more heavily used there. And over the counter, like you said. Yeah, and over the counter. Yeah. And Kelsey said, no, no, no, we're not going to do it before anyone else did. And she is the reason that it was never released in the United States. although a handful of kids in the United States were born. Maybe I didn't see an explanation of how that happened.
I think there was like less than 20, but I guess they got their hands on some thalidomide somehow. Yeah, their parents could have been traveling in Europe, especially if you take thalidomide early in pregnancy. Yeah, that makes sense. So they knew that thalidomide led to a whole just grab bag of different birth defects, like you were saying. But it wasn't until about 60 years after it got pulled from shelves that they finally figured out why. And what they realized is that with most drugs, it goes and binds to a specific receptor site. And maybe it prevents the reuptake of, say, serotonin. So you have more serotonin flowing through your system, and that helps balance that neurochemical.
Well, thalidomide binds to all sorts of different stuff, specifically lots of different proteins. And those proteins do things like turn genes on and off. And because it's so non-preferential with what proteins it binds to, it can bind to all sorts of different proteins that are responsible for all sorts of different genes. And when those genes aren't turned on or aren't turned off, you can develop a foot on your shoulder, that kind of thing. And that's why thalidomide caused all those birth defects. That's right. And in the end, like you mentioned, Kelsey was somewhat sung in her lifetime. There was a big, and this article points out from How Stuff Works, that she probably would have been unsung had it not been for this great article on the Washington Post that was published back then in 1962 about her.
And that caused President John F. Kennedy to stand up and say, here is the President's Award for Distinguished Federal Civilian Service for doing that thing you did. That was more Teddy Kennedy, I think. Teddy Kennedy. But more importantly, the Kefalver Harris Amendment went into law, which was the legislation that really tightened up how the FDA approves things and not only tightened up, but lengthened and made the process more rigorous. Yeah. And she stayed on for 45 more years and helped kind of shape the approval process for drugs at the FDA. I hope she got a better office. I hope she did too, a corner one too.
And there's plenty of stuff you can say about the approval process at the FDA, especially these days, but it's better than 60-day window. That's true. Chuck said that's true, everybody, and that triggers short stuff being out. Stuff You Should Know is a production of iHeartRadio. For more podcasts from iHeartRadio, visit the iHeartRadio app, Apple Podcasts, or wherever you listen to your favorite shows.